These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 32671960)
1. Cytomegalovirus esophagitis with symptoms of gastroesophageal reflux disease in a kidney transplant recipient. Chen YJ; Huang HC; Chen TC; Cheng HT Kaohsiung J Med Sci; 2020 Oct; 36(10):859-860. PubMed ID: 32671960 [No Abstract] [Full Text] [Related]
2. Underdosing of prophylactic valganciclovir due to inaccurate estimation of glomerular filtration rate leading to severe cytomegalovirus disease in a kidney transplant recipient. Penne EL; Nurmohamed SA Antimicrob Agents Chemother; 2014; 58(2):1271-2. PubMed ID: 24470493 [No Abstract] [Full Text] [Related]
3. Cytomegalovirus esophagitis presents as chest pain in a renal transplant recipient. Joo YB; Jung HS; Baeg MK; Lee WH; Lee HJ; Yang CW Korean J Intern Med; 2013 Jul; 28(4):497-9. PubMed ID: 23864810 [No Abstract] [Full Text] [Related]
4. A Unique Case of Esophagitis in an Immunocompromised Patient. Akman O; Gheorghe R; Bernstein CN Gastroenterology; 2021 Sep; 161(3):e8-e9. PubMed ID: 33610531 [No Abstract] [Full Text] [Related]
5. Efficacy and Safety of Low-Dose Versus Standard-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Intermediate-Risk Kidney Transplant Recipients. Halim MA; Al-Otaibi T; Gheith O; Adel H; Mosaad A; Hasaneen AA; Zakaria Z; Makkeya Y; Said T; Nair P Exp Clin Transplant; 2016 Oct; 14(5):526-534. PubMed ID: 27310254 [TBL] [Abstract][Full Text] [Related]
7. Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation. Manuel O; Perrottet N; Pascual M Expert Rev Anti Infect Ther; 2011 Nov; 9(11):955-65. PubMed ID: 22029513 [TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus prophylaxis with valganciclovir in cytomegalovirus-seropositive kidney-transplant patients. Wéclawiak H; Kamar N; Mengelle C; Guitard J; Esposito L; Lavayssière L; Cointault O; Ribes D; Rostaing L J Med Virol; 2008 Jul; 80(7):1228-32. PubMed ID: 18461614 [TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus renal infection: Rare manifestation of a common post-transplant viral infection-A case series. Posadas Salas MA; Thompson J; Kadian M; Ngo T; Bruner E; Self S Transpl Infect Dis; 2019 Dec; 21(6):e13169. PubMed ID: 31498951 [TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus oesophagitis following treatment with fludarabine for refractory lymphoplasmacytic lymphoma. Pyatt N; Mitra S BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22771414 [TBL] [Abstract][Full Text] [Related]
11. Multiple 'doughnut' granulomas in a liver transplant patient with CMV reactivation. Dejhansathit S; Miller AM; Suvannasankha A BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30580302 [No Abstract] [Full Text] [Related]
12. Persistent primary cytomegalovirus infection in a kidney transplant recipient: Multi-drug resistant and compartmentalized infection leading to graft loss. Andrei G; Van Loon E; Lerut E; Victoor J; Meijers B; Bammens B; Sprangers B; Gillemot S; Fiten P; Opdenakker G; Lagrou K; Kuypers D; Snoeck R; Naesens M Antiviral Res; 2019 Aug; 168():203-209. PubMed ID: 31212020 [TBL] [Abstract][Full Text] [Related]
13. The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the 'silo hypothesis'. Rubin RH Curr Opin Infect Dis; 2007 Aug; 20(4):399-407. PubMed ID: 17609600 [TBL] [Abstract][Full Text] [Related]
14. Low dose valganciclovir as cytomegalovirus prophylaxis in post-renal transplant recipients induced with alemtuzumab: A single-center study. Korneffel K; Mitro G; Buschor K; Rees M; Ortiz J Transpl Immunol; 2019 Oct; 56():101226. PubMed ID: 31344441 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant Recipients. Liu AW; Jutivorakool K; Fisher CE; Rakita RM; Reyes JD; Bhattacharya RB; Jerome KR; Limaye AP Transplantation; 2018 Apr; 102(4):632-639. PubMed ID: 29215460 [TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus esophagitis in a child with human immunodeficiency virus-1 infection presenting as fever of unknown origin and stunted growth. Madsen M; Nielsen H Eur J Pediatr; 2006 Sep; 165(9):665-6. PubMed ID: 16642367 [TBL] [Abstract][Full Text] [Related]
17. Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients. Reischig T; Prucha M; Sedlackova L; Lysak D; Jindra P; Bouda M; Matejovic M Antivir Ther; 2011; 16(8):1227-35. PubMed ID: 22155904 [TBL] [Abstract][Full Text] [Related]
18. Editorial commentary: Use of valganciclovir for prevention and treatment of cytomegalovirus disease. Snydman DR Clin Infect Dis; 2008 Jan; 46(1):28-9. PubMed ID: 18171209 [No Abstract] [Full Text] [Related]
19. Combination Treatment With Letermovir and Ganciclovir for Maintenance Therapy of Multidrug-resistant CMV Infection in a Liver Transplant Recipient. Kronig I; Elkrief L; Berney T; Van Delden C; Neofytos D Transplantation; 2020 Aug; 104(8):e248-e249. PubMed ID: 32732860 [No Abstract] [Full Text] [Related]
20. Human cytomegalovirus and kidney transplantation: a clinician's update. De Keyzer K; Van Laecke S; Peeters P; Vanholder R Am J Kidney Dis; 2011 Jul; 58(1):118-26. PubMed ID: 21684438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]